202 related articles for article (PubMed ID: 3421765)
21. BMS-181184, a new pradimicin derivative. Screening, taxonomy, directed biosynthesis, isolation and characterization.
Furumai T; Saitoh K; Kakushima M; Yamamoto S; Suzuki K; Ikeda C; Kobaru S; Hatori M; Oki T
J Antibiot (Tokyo); 1993 Feb; 46(2):265-74. PubMed ID: 8468241
[TBL] [Abstract][Full Text] [Related]
22. Studies on a new antitumor antibiotic, largomycin. II. Isolation, purification and physicochemical properties.
Yamaguchi T; Kashida T; Nawa K; Yajima T; Miyagishi T
J Antibiot (Tokyo); 1970 Aug; 23(8):373-81. PubMed ID: 5453313
[No Abstract] [Full Text] [Related]
23. Studies on marine microorganisms. IV. A new antibiotic SS-228 Y produced by Chainia isolated from shallow sea mud.
Okazaki T; Kitahara T; Okami Y
J Antibiot (Tokyo); 1975 Mar; 28(3):176-84. PubMed ID: 1126873
[TBL] [Abstract][Full Text] [Related]
24. [New anthracycline antibiotics taurimycins A and B produced by a Str. tauricus No. 7036-1 culture].
Frolova VI; Kuzovkov AD; Rozynov BV; Taĭg MM; Ivanitskaia LP
Antibiotiki; 1982 May; 27(5):326-31. PubMed ID: 6954874
[TBL] [Abstract][Full Text] [Related]
25. Epoxomicin, a new antitumor agent of microbial origin.
Hanada M; Sugawara K; Kaneta K; Toda S; Nishiyama Y; Tomita K; Yamamoto H; Konishi M; Oki T
J Antibiot (Tokyo); 1992 Nov; 45(11):1746-52. PubMed ID: 1468981
[TBL] [Abstract][Full Text] [Related]
26. Leukaemomycin, in antibiotic with antitumor activity. II. Isolation and identification.
Strauss D; Fleck W
Z Allg Mikrobiol; 1975; 15(8):615-23. PubMed ID: 816099
[TBL] [Abstract][Full Text] [Related]
27. [Induction of antibiotic formation by inactive cultures of actinomycetes. A mutant strain of Streptomyces helvaticus, a new producer of bruneomycin].
Malkina ND; Dudnik IuV; Lysenkova LN; Terekhova LP; Katrukha GS
Antibiot Khimioter; 1995 Jun; 40(6):3-6. PubMed ID: 8593091
[TBL] [Abstract][Full Text] [Related]
28. [The antibiotic galtamycin. The structure of galtamycinone].
Murenets NV; Kudinova MK; Kliuev NA; Chernyshev AI; Shorshnev SV
Antibiot Med Biotekhnol; 1986 Jun; 31(6):431-4. PubMed ID: 3017199
[TBL] [Abstract][Full Text] [Related]
29. [Physicochmemical characteristics of the new antineoplastic antibiotic, nocamycin].
Brazhnikova MG; Konstantinova NV; Potapova NP; Tolstykh IV
Antibiotiki; 1977 Jun; 22(6):486-9. PubMed ID: 18980
[TBL] [Abstract][Full Text] [Related]
30. [Physico-chemical properties of antineoplastic antibiotic rubomycin formed by Act. coeruleorubidus].
Brazhnikova MG; Konstantinova NV; Pomazhova VA; Zakharov GV
Antibiotiki; 1966 Sep; 11(9):763-7. PubMed ID: 5996873
[No Abstract] [Full Text] [Related]
31. A new antitumor antibiotic, FR900840. II. Structural elucidation of FR900840.
Nishimura M; Nakada H; Takase S; Katayama A; Goto T; Tanaka H; Hashimoto M
J Antibiot (Tokyo); 1989 Apr; 42(4):549-52. PubMed ID: 2498270
[TBL] [Abstract][Full Text] [Related]
32. Viriplanin A, a new anthracycline antibiotic of the nogalamycin group. I. Isolation, characterization, degradation reactions and biological properties.
Hütter K; Baader E; Frobel K; Zeeck A; Bauer K; Gau W; Kurz J; Schröder T; Wünsche C; Karl W
J Antibiot (Tokyo); 1986 Sep; 39(9):1193-204. PubMed ID: 3023268
[TBL] [Abstract][Full Text] [Related]
33. New antitumor antibiotic, LL-C10037 alpha. Fermentation, isolation and structure determination.
Lee MD; Fantini AA; Morton GO; James JC; Borders DB; Testa RT
J Antibiot (Tokyo); 1984 Oct; 37(10):1149-52. PubMed ID: 6548735
[TBL] [Abstract][Full Text] [Related]
34. Glycothiohexide alpha, a novel antibiotic produced by "Sebekia" sp., LL-14E605. II. Isolation and physical-chemical characterization.
Northcote PT; Williams D; Manning JK; Borders DB; Maiese WM; Lee MD
J Antibiot (Tokyo); 1994 Aug; 47(8):894-900. PubMed ID: 7928676
[TBL] [Abstract][Full Text] [Related]
35. Studies on auromomycin.
Yamashita T; Naoi N; Hidaka T; Watanabe K; Kumada Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1979 Apr; 32(4):330-9. PubMed ID: 468720
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. II. Structure elucidation.
Kettenring J; Colombo L; Ferrari P; Tavecchia P; Nebuloni M; Vékey K; Gallo GG; Selva E
J Antibiot (Tokyo); 1991 Jul; 44(7):702-15. PubMed ID: 1880060
[TBL] [Abstract][Full Text] [Related]
37. New antitumor antibiotics, FR-900405 and FR-900406. II. Production, isolation, characterization and antitumor activity.
Kiyoto S; Nishikawa M; Terano H; Kohsaka M; Aoki H; Imanaka H; Kawai Y; Uchida I; Hashimoto M
J Antibiot (Tokyo); 1985 Jul; 38(7):840-8. PubMed ID: 4030499
[TBL] [Abstract][Full Text] [Related]
38. BBM-928, a new antitumor antibiotic complex. III. Structure determination of BBM-928 A, B and C.
Konishi M; Ohkuma H; Sakai F; Tsuno T; Koshiyama H; Naito T; Kawaguchi H
J Antibiot (Tokyo); 1981 Feb; 34(2):148-59. PubMed ID: 7298509
[TBL] [Abstract][Full Text] [Related]
39. New antifungal antibiotics, pradimicins D and E. Glycine analogs of pradimicins A and C.
Sawada Y; Nishio M; Yamamoto H; Hatori M; Miyaki T; Konishi M; Oki T
J Antibiot (Tokyo); 1990 Jul; 43(7):771-7. PubMed ID: 2387770
[TBL] [Abstract][Full Text] [Related]
40. [Minor components from the carminomycin complex].
Zbarskiĭ VB; Potapova NP; Olsuf'eva EN; Rubasheva LM; Brazhnikova MG
Antibiotiki; 1980 Jul; 25(7):492-5. PubMed ID: 6250461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]